Author: Blagojevic, Nikola R.; Bosnjakovic, Dragana; Vukomanovic, Vladan; Arsenovic, Srdjan; Lazic, Jelena Suzic; Tadic, Marijana
Title: Acute pericarditis and SARS-CoV-2: case report Cord-id: vugijc7r Document date: 2020_9_28
ID: vugijc7r
Snippet: We present a case of a 51-year-old patient with acute pericarditis as the dominant manifestation of SARS-CoV-2 infection. The patient was admitted to the emergency department during a COVID-19 outbreak with a suspected ST-elevation myocardial infarction. Coronary angiogram was normal. The real-time reverse transcriptase PCR assay for the detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab was positive. The laboratory tests revealed increased white blood cell count, with neutrophilia
Document: We present a case of a 51-year-old patient with acute pericarditis as the dominant manifestation of SARS-CoV-2 infection. The patient was admitted to the emergency department during a COVID-19 outbreak with a suspected ST-elevation myocardial infarction. Coronary angiogram was normal. The real-time reverse transcriptase PCR assay for the detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab was positive. The laboratory tests revealed increased white blood cell count, with neutrophilia and lymphocytopenia, elevated level of C reactive protein, borderline ESR and slightly elevated interleukin-6. Echocardiography showed hyperechogenic pericardium posterolaterally with minimal localized pericardial effusion. A chest computed tomography scan showed a small zone of ground-glass opacity of the right lower lobe (classified as CO-RADS 3). In patients with chest pain, ST elevation on ECG, normal coronary angiogram, and suspected COVID-19, we should think of the pericarditis, as unusual SARS-CoV-2 infection presentation.
Search related documents:
Co phrase search for related documents- acute phase and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase and lopinavir mg ritonavir: 1, 2
- acute phase and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lobe volume: 1
- acute respiratory and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute respiratory and lopinavir mg ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute respiratory and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lung injury induce: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- lobe volume and long term outcome: 1
- long term outcome and lung injury: 1, 2, 3
- long term outcome and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- lopinavir mg ritonavir and lung injury: 1, 2
- lopinavir mg ritonavir and magnetic resonance: 1, 2
- lung injury and magnetic resonance: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date